Therefore, when loading anticancer agent into LDL particles will increase the binding to LDL-receptor which lead to endocytosis targeting microtubules as explained in Figure 8 and cause cancer cell death which is proved from the in-vitro assays’ data (Jaragh-Alhadad et al., 2022b). Here, LDLR is linked to cancer.